BioMarin Pharma (BMRN) – Analyst EPS View
-
BioMarin Pharmaceutical Inc. (BMRN) PT Raised to $108 at BMO Capital
-
Sarepta Therapeutics (SRPT) Shares Should Nearly Double - Nomura/Instinet
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
Back to BMRN Stock Lookup